These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 26459747)

  • 1. GC-MS-based metabolomic analysis of human papillary thyroid carcinoma tissue.
    Chen M; Shen M; Li Y; Liu C; Zhou K; Hu W; Xu B; Xia Y; Tang W
    Int J Mol Med; 2015 Dec; 36(6):1607-14. PubMed ID: 26459747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic changes associated with papillary thyroid carcinoma: A nuclear magnetic resonance-based metabolomics study.
    Li Y; Chen M; Liu C; Xia Y; Xu B; Hu Y; Chen T; Shen M; Tang W
    Int J Mol Med; 2018 May; 41(5):3006-3014. PubMed ID: 29484373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct Metabolomic Profiles of Papillary Thyroid Carcinoma and Benign Thyroid Adenoma.
    Xu Y; Zheng X; Qiu Y; Jia W; Wang J; Yin S
    J Proteome Res; 2015 Aug; 14(8):3315-21. PubMed ID: 26130307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapy.
    Shang X; Zhong X; Tian X
    Tumour Biol; 2016 Aug; 37(8):11163-75. PubMed ID: 26935059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A distinct serum metabolic signature of distant metastatic papillary thyroid carcinoma.
    Shen CT; Zhang Y; Liu YM; Yin S; Zhang XY; Wei WJ; Sun ZK; Song HJ; Qiu ZL; Wang CR; Luo QY
    Clin Endocrinol (Oxf); 2017 Dec; 87(6):844-852. PubMed ID: 28755525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.
    Ngan ES; Lang BH; Liu T; Shum CK; So MT; Lau DK; Leon TY; Cherny SS; Tsai SY; Lo CY; Khoo US; Tam PK; Garcia-Barceló MM
    J Natl Cancer Inst; 2009 Feb; 101(3):162-75. PubMed ID: 19176457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells.
    Degl'Innocenti D; Romeo P; Tarantino E; Sensi M; Cassinelli G; Catalano V; Lanzi C; Perrone F; Pilotti S; Seregni E; Pierotti MA; Greco A; Borrello MG
    Endocr Relat Cancer; 2013 Feb; 20(1):23-37. PubMed ID: 23132790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preliminary findings for metabolite profiles of papillary thyroid carcinoma and laryngeal squamous cell carcinoma].
    Fei MJ; Xu YN; Wang JD
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Oct; 31(20):1561-1565. PubMed ID: 29797950
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatocyte growth factor receptor, matrix metalloproteinase-11, tissue inhibitor of metalloproteinase-1, and fibronectin are up-regulated in papillary thyroid carcinoma: a cDNA and tissue microarray study.
    Wasenius VM; Hemmer S; Kettunen E; Knuutila S; Franssila K; Joensuu H
    Clin Cancer Res; 2003 Jan; 9(1):68-75. PubMed ID: 12538453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of prostaglandin E2 and EP receptors in human papillary thyroid carcinoma.
    Sun L; Wei X; Liu X; Zhou D; Hu F; Zeng Y; Sun Y; Luo S; Zhang Y; Yi XP
    Tumour Biol; 2016 Apr; 37(4):4689-97. PubMed ID: 26511970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of the urokinase plasminogen activator and its cognate receptor associates with advanced stages and reduced disease-free interval in papillary thyroid carcinoma.
    Ulisse S; Baldini E; Sorrenti S; Barollo S; Gnessi L; Catania A; Pellizzo MR; Nardi F; Mian C; De Antoni E; D'Armiento M; Frati L
    J Clin Endocrinol Metab; 2011 Feb; 96(2):504-8. PubMed ID: 21106716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression in poorly differentiated papillary thyroid carcinomas.
    Fluge Ø; Bruland O; Akslen LA; Lillehaug JR; Varhaug JE
    Thyroid; 2006 Feb; 16(2):161-75. PubMed ID: 16676402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue metabolomic fingerprinting reveals metabolic disorders associated with human gastric cancer morbidity.
    Song H; Wang L; Liu HL; Wu XB; Wang HS; Liu ZH; Li Y; Diao DC; Chen HL; Peng JS
    Oncol Rep; 2011 Aug; 26(2):431-8. PubMed ID: 21567103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum-plasma matched metabolomics for comprehensive characterization of benign thyroid nodule and papillary thyroid carcinoma.
    Huang FQ; Li J; Jiang L; Wang FX; Alolga RN; Wang MJ; Min WJ; Ma G; Zhao YJ; Wang SL; Yu Y; Chen X; Zhu D; Zhu J; Wang G; Xia T; Sang JF; Lai MD; Li P; Zhu W; Qi LW
    Int J Cancer; 2019 Feb; 144(4):868-876. PubMed ID: 30318614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide expression analysis of Middle Eastern papillary thyroid cancer reveals c-MET as a novel target for cancer therapy.
    Siraj AK; Bavi P; Abubaker J; Jehan Z; Sultana M; Al-Dayel F; Al-Nuaim A; Alzahrani A; Ahmed M; Al-Sanea O; Uddin S; Al-Kuraya KS
    J Pathol; 2007 Oct; 213(2):190-9. PubMed ID: 17703498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolomic investigation into variation of endogenous metabolites in professional athletes subject to strength-endurance training.
    Yan B; A J; Wang G; Lu H; Huang X; Liu Y; Zha W; Hao H; Zhang Y; Liu L; Gu S; Huang Q; Zheng Y; Sun J
    J Appl Physiol (1985); 2009 Feb; 106(2):531-8. PubMed ID: 19036890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological roles of alterations of tumor suppressor gene p16 in papillary thyroid carcinoma.
    Lam AK; Lo CY; Leung P; Lang BH; Chan WF; Luk JM
    Ann Surg Oncol; 2007 May; 14(5):1772-9. PubMed ID: 17195959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
    Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
    J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intercellular adhesion molecule-1 (ICAM-1) is upregulated in aggressive papillary thyroid carcinoma.
    Buitrago D; Keutgen XM; Crowley M; Filicori F; Aldailami H; Hoda R; Liu YF; Hoda RS; Scognamiglio T; Jin M; Fahey TJ; Zarnegar R
    Ann Surg Oncol; 2012 Mar; 19(3):973-80. PubMed ID: 21879273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and clinical significance of FOXE1 in papillary thyroid carcinoma.
    Fan Y; Ding Z; Yang Z; Deng X; Kang J; Wu B; Zheng Q
    Mol Med Rep; 2013 Jul; 8(1):123-7. PubMed ID: 23715628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.